There was increased expression of IL-31RA in the epidermal skin (p = 0.016) from AD subjects post-MTX treatment and no significant difference in the superficial dermis (p = 0.151) (Figure 1, Figure 2). The gene discussed is IL31RA; the disease is Alzheimer disease.